Delivery Order SPE2DR25D2101-SPE2DR26F47KN
Award Date 1/16/26
Potential Completion Date 1/20/26
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,813.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 8, 2025. This competitively awarded, non-set-aside contract represents a single delivery order for a contrast media pharmaceutical product commonly used in diagnostic imaging procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $6,475.92 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100 ml bottles, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order, valued at $2,322.46, was competitively awarded without a set-aside designation and carries a completion date of December 12, 2025. AmerisourceBergen will perform delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,299.90 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed-price contract was issued on January 13, 2026, with a completion date of January 14, 2026, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $3,379.74 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Visipaque 320 mg/ml in 100ml bottles, with completion scheduled for January 5, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Visipaque is a contrast agent used in medical imaging procedures, representing part of the broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,597.96 to supply Visipaque 320 mg/mL infusion bottles (150 mL) with an ultimate completion date of December 9, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and...
- The Defense Logistics Agency awarded a $1,819.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VISIPAQUE 320 mg/ml in 100ml bottles, with an ultimate completion date of January 9, 2026. This contract is a non-set-aside award, competitively issued and fulfilled by the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,337.80 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of October 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical supply procurement needs. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Visipaque 320 mg/mL infusion bottles (150 mL units) with a ceiling value of $1,753.42. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by November 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...